Fig. 1From: Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencingInclusion and diagnostic strategy for targeted NGS in patients with primary PP. TPP: thyrotoxic periodic paralysis. CMAP: compound muscle action potentialBack to article page